According to a market report by Lucintel, the future of the global uterine cancer diagnostics market looks promising with opportunities in the hospital, diagnostic center, and cancer research center markets. The global uterine cancer diagnostics market is expected to reach an estimated $11 billion by 2030 with a CAGR of 9% from 2024 to 2030. The major drivers for this market are the increasing cases of uterine cancer, technological advancement in uterine cancer diagnostics, and the growing prevalence of obesity among women worldwide.
A more
than 150-page report to understand trends, opportunity and forecast in global uterine
cancer diagnostics market to 2030 by diagnostic type (instrument based and
procedure based), type (endometrial cancer and uterine sarcoma), age group
(<30, 31-40, 41-50, 51-60 , and >60), end use (hospitals, diagnostic
centers, cancer research center, and others), and region (North America,
Europe, Asia Pacific, and the Rest of the World).
Lucintel
forecasts that, within the diagnostic type category, instrument based is
expected to witness a higher growth over the forecast period due to evolution
of diagnostic imaging technology, resulting in heightened precision.
Within the
end use category, hospitals will remain the largest segment due to increasing
prevalence of cancer cases, growing demand for minimally invasive advanced
screening techniques, and rising investments and funding in cancer diagnostics
in hospitals.
Download
sample by clicking on uterine
cancer diagnostics market.
In terms
of regions, North America will remain the largest region over the forecast
period due to growing incidence rate of uterine cancer in the US, emphasizing
the significance of timely detection and preventive measures to combat cancer,
and increasing number of various cancer awareness programs by the government.
Siemens
Healthcare, Narang Medical, F-Hoffmann La Roche, Esaote, Samsung Medison,
Olympus, Arquer Diagnostics, Guzip Biomarkers, General Electric, Canon Medical are
the major suppliers in the uterine
cancer diagnostics market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Exosome Extraction System Market
Extended Reach Drilling Market
Homogeneous Sterile Sampling Bag Market
Hysteroscopic Tissue Removal System Market
Identity Security Posture Management Market
No comments:
Post a Comment